MedTrace Logo

Exploring Acceptance and Outcomes of an Online-based Self-management Support System in Chronic Illness

NCT02832739 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-07-11

No results posted yet for this study

Summary

The aim of the USECARE project is to improve and test SENACA, an ICT-based self-management support system for chronically ill patients and informal caregivers. 60 end-users will be instructed to use SENACA for approx. 3 months (in Israel and Norway). Amongst others, clinical and behavioural outcomes will be recorded. Additionally, SENACA's usability will be evaluated to determine its potential future scalability.

Conditions

Interventions

DEVICE

SENACA - ICT based self-management support system

SENACA - ICT based self-management support system is a structured self-management support system with several interacting components, combining tele-monitoring devices and a solution for personalised health plans. ==\> www.senaca.ch

Sponsors & Collaborators

  • Norwegian Centre for Integrated Care and Telemedicine (NST)

    collaborator UNKNOWN

  • Open-Evidence c/o Universitat Oberta de Catalunya

    collaborator UNKNOWN

  • Institute for Health and Consumer Protection c/o University of Oslo, Faculty of Medicine

    collaborator UNKNOWN

  • European Medical Network EMN AG

    collaborator UNKNOWN

  • Assuta Medical Center

    lead OTHER

Principal Investigators

  • Frank Larsen, MA · Norwegian Centre for Integrated Care and Telemedicine

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • Israel
  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02832739 on ClinicalTrials.gov